Login / Signup

Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs.

Ashish SharmaNilesh KumarNikulaa ParachuriFrancesco Maria BandelloAnat LoewensteinBaruch D Kuppermann
Published in: Eye (London, England) (2024)
Keyphrases
  • clinical trial
  • diabetic retinopathy
  • age related macular degeneration
  • phase ii
  • open label
  • double blind
  • study protocol
  • randomized controlled trial
  • optical coherence tomography